Tumor cell-released autophagosomes from mouse cancer cell lines were found to stimulate the development of splenic B cells into CD1d + CD5 + IL10+ Bregs, which could potently suppress CD8+ and CD4+ T cell actions in vitro and in vivo [318]. The gene discussed is CD4; the disease is cancer.